|
jessica weedJessica Weed is a Clinical Research Coordinator for the University of Alabama in Birmingham where she serves on a research team with a primary focus of developing new ways to treat and prevent depression and suicide. She earned her Bachelor of Arts degree in Psychology with a minor in Sociology from Athens State University. While working towards her degree she collaborated on the Alabama Higher Education Suicide Prevention Program (AHESPP) grant from the Alabama Department of Public Health (ADPH) and was later sub-awarded the grant for it’s third year at the University. In addition to her work on suicide prevention and awareness, Jessica also completed an i
|
nternship at Limestone Correctional Facility in Harvest, Alabama in which she developed and facilitated mental health workshops and course material to be delivered onsite for inmates. She also participated in the Inside-Out Prison Exchange Program; a program with the goal of facilitating dialogue and education across profound social differences by combining incarcerated students and university students in courses held inside prison. It was during this time she developed a special interest in working with incarcerated individuals, specifically assessment and treatment of personality disorders within this population.
Additionally, she has experience working with children diagnosed with autism, Oppositional Defiant Disorder (ODD), Attention Deficit Hyperactivity Disorder (ADHD), and sensory processing disorders. This line of work was focused on testing and assessment of behavioral disorders, as well as implementing therapeutic interventions in the home and in clinical settings. In her current role, she coordinates research projects looking at the effectiveness of various treatments for individuals with treatment-resistant depression and identifying biomarkers of both disease and treatment response in depressed and suicidal individuals.
Additionally, she has experience working with children diagnosed with autism, Oppositional Defiant Disorder (ODD), Attention Deficit Hyperactivity Disorder (ADHD), and sensory processing disorders. This line of work was focused on testing and assessment of behavioral disorders, as well as implementing therapeutic interventions in the home and in clinical settings. In her current role, she coordinates research projects looking at the effectiveness of various treatments for individuals with treatment-resistant depression and identifying biomarkers of both disease and treatment response in depressed and suicidal individuals.